|
|
|
Volumn 34, Issue 2, 1998, Pages 1-6
|
|
Superficial bladder cancer, including T1G3 disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCG VACCINE;
BROPIRIMINE;
CYTOKINE;
DOXORUBICIN;
EPIRUBICIN;
INTERFERON;
ISONIAZID;
KEYHOLE LIMPET HEMOCYANIN;
MITOMYCIN C;
PROTEIN P53;
THIOTEPA;
TUBERCULOSTATIC AGENT;
TUMOR MARKER;
ADJUVANT CHEMOTHERAPY;
ALLERGIC REACTION;
BLADDER CANCER;
BONE MARROW SUPPRESSION;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CANCER SURVIVAL;
CYSTITIS;
DRUG CHOICE;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOXICITY;
DRUG WITHDRAWAL;
FEVER;
HIGH RISK PATIENT;
HUMAN;
INTRAVESICAL DRUG ADMINISTRATION;
LIVER TOXICITY;
MAINTENANCE THERAPY;
MALAISE;
NAUSEA;
PLOIDY;
PRIORITY JOURNAL;
REVIEW;
SUPERFICIAL CANCER;
TUMOR GROWTH;
|
|
EID: 0031655781
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (19)
|
